Check whether you already have access via your university or organisation.
艾迪药业的国际多中心临床研究项目，正是瞄准这一市场痛点，计划完成整合酶抑制剂药物在美国的Ⅲ期临床试验并申报NDA，借助美国抗艾政策与审批通道拓展海外业务。
，详情可参考heLLoword翻译官方下载
Michael J. Sullivan ,
FirstFT: the day's biggest stories
insecurely. Serhiy noted that at the time, this was just one of three